Review Article
Accelerated Kidney Aging in Diabetes Mellitus
Table 1
Comparison between SASP and DN-associated secretory phenotype.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abbreviations: SASP: senescence-associated secretory phenotype; IL: interleukin; TNF-α: tumor necrosis factor α; TWEAK: apoptosis of tumor necrosis factor-like weak inducer; ICAM-1: intercellular adhesion molecule 1; VCAM-1: vascular cell adhesion molecule 1; CXCL: C-X-C-motif chemokine ligand; CCL: C-C-motif chemokine ligand; MCP: monocyte chemoattractant protein; MIP: macrophage inflammatory protein; GM-CSF: granulocyte-macrophage colony-stimulating factor; G-CSF: granulocyte colony-stimulating factor; IFN-γ: interferon-γ; IGFBP: insulin-like growth factor binding protein; TGF-β: transforming growth factor -β; VEGF: vascular endothelial growth factor; PDGF: platelet-derived growth factor; FGF: fibroblast growth factor; MMP: matrix metalloproteinase; TIMP: tissue inhibitors of metalloproteinases-1; PAI-1: plasminogen activator inhibitor -1; iNOS: inducible nitric oxide synthase; ROS: reactive oxygen species; COX-2: cyclooxygenase-2; NOX-4: NADPH oxidase-4; SOD: superoxide dismutase; MDA: administration; Upward arrows, crosses, and downward arrows show secretory increase, no change and decrease in senescence, respectively. |